Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Biological evaluation within a risk management process].

Fei Zhuang1, Biao Ding

  • 1Shanghai Testing & Inspection Institute for Medical Devices.

Zhongguo Yi Liao Qi Xie Za Zhi = Chinese Journal of Medical Instrumentation
|November 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An optimized prime editing system for precise genome editing in soybean.

Plant communications·2026
Same author

The role of RARG in solid tumor progression and therapeutic potential.

Discover oncology·2026
Same author

Epithelial Cell-Specific Prognostic Signature (FTH1, RIT1, WASL, NDRG2, KIFC3) Stratifies Cervical Cancer Patients and Correlates With Immune Infiltration.

Human mutation·2026
Same author

HIF-2α / HILPDA promotes ferroptosis sensitivity in placenta trophoblast cells of early-onset preeclampsia.

Placenta·2025
Same author

Exercise-derived peptide confers protection against septic cardiomyopathy by enhancing CCAAT/enhancer binding protein β-mediated autophagy.

Cellular and molecular life sciences : CMLS·2025
Same author

Identification and validation of expression and functions of ferroptosis-related gene HILPDA in early-onset preeclampsia placentas.

Frontiers in immunology·2025
Same journal

[Study on <i>In Vitro</i> Chromosome Aberration Test for Nanomaterials and Medical Devices Containing Nanomaterials].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Research on the Coordinated Mechanism of Medical Device Research and Evaluation in China and the United States].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Research and Countermeasure Analysis on the Classification of Brain-Computer Interface Rehabilitation Medical Devices].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Development of Portable Sleep Monitoring System].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Design and Application of 3D-Printed Individualized Pelvic Prostheses].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Study on Standardization Methods of Multi-Source Heterogeneous Data from ICU Medical Devices Based on openEHR].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
See all related articles

Bio-evaluation within medical device quality systems involves risk assessment using material data and testing. Application history is crucial, as no testing perfectly mimics the human body, influencing product design decisions.

Area of Science:

  • Biocompatibility and Medical Device Regulation
  • Risk Management in Healthcare Technology

Context:

  • Bio-evaluation is integral to medical device quality and risk management.
  • It involves analyzing material data, literature, application history, and toxicology testing.
  • The process weighs benefits against risks to determine product viability.

Purpose:

  • To outline the comprehensive process of bio-evaluation for medical devices.
  • To highlight the importance of application history data over purely toxicological testing.
  • To discuss the integration of bio-evaluation into overall quality and risk management frameworks.

Summary:

  • Bio-evaluation assesses risks by integrating data from material characterization, literature, application history, and toxicology.
  • The goal is to decide whether to proceed with a product design, acknowledging that zero risk is unattainable.

Related Experiment Videos

  • Application history provides the most holistic data, surpassing in vitro or in vivo testing limitations.
  • Cost-effectiveness of advanced testing technologies is also a consideration.

    • Impact:

    • Informs regulatory trends, such as changes in ISO 10993-1 and FDA CDRH guidance (#G95-1).
    • Promotes a more integrated approach to medical device development and safety assurance.
    • Emphasizes a pragmatic view of risk, moving beyond the ideal of zero toxicity.